Editorial Scope
Peptide Forge publishes manufacturing-grade technical documentation for research peptides. Every profile is written for a B2B audience — process chemists, QC laboratory managers, regulatory affairs leads, procurement officers, and supply-chain analysts. The goal is precision and density: the kind of information that belongs in a quality dossier, not a marketing brochure.
The library currently covers twenty manufacturing profiles in continuous review. Each profile is structured around the same canonical sections: synthesis methodology, purification, analytical characterization, lyophilization, stability, batch documentation, and supply-chain considerations. The structural consistency is deliberate — quality and procurement readers should be able to navigate any profile in the library by section without re-learning the layout.
Methodology
Documentation in this library is anchored to four regulatory and standards-setting bodies: the U.S. Food and Drug Administration (cGMP, data integrity, guidance for industry), the International Council for Harmonisation (ICH Q-series quality guidelines), the United States Pharmacopeia (USP general chapters and monographs), and the International Organization for Standardization (ISO 9001 and adjacent QMS standards). Industry technical references — ISPE Baseline Guides, PDA Technical Reports, IPEC excipient guidelines — supplement these where relevant.
Specifications are written to reflect industry-standard practice for pharmaceutical-grade peptide manufacturing. They are not facility-specific: a reader applying these references to a particular production site must adapt the numerical parameters to that site's qualified equipment, validated processes, and regulatory commitments.
Coverage Per Profile
- Synthesis: SPPS chemistry selection (Fmoc vs Boc), resin choice, coupling reagents, deprotection sequence, in-process monitoring, and difficult-sequence strategies.
- Purification: Crude characterization, preparative RP-HPLC method, gradient design, fraction-pooling acceptance criteria, ion-exchange polishing where applicable.
- Analytical Release: Identity by MS, purity by HPLC, content determination, AAA, residual solvents (ICH Q3C), endotoxin (USP <85>), bioburden (USP <61> / <62>), counter-ion analysis.
- Lyophilization: Formulation excipients, cycle parameters (freezing, primary drying, secondary drying), residual moisture spec, vial-load uniformity.
- Stability: ICH Q1A(R2) study design, accelerated and long-term arms, stability-indicating method, degradation pathway characterization.
- Documentation: Master batch record contents, executed batch record review, deviation/CAPA handling, change control gates, DMF / CEP filing considerations.
- Supply Chain: Raw material qualification, supplier audit cadence, FEFO inventory, cold-chain handling, distribution logistics.
Editorial Team
Marcus Reinhardt is the editorial lead for the Peptide Forge library. His twenty-two-year career in pharmaceutical peptide manufacturing spans solid-phase synthesis scale-up, preparative chromatography process development, lyophilization cycle qualification, and FDA pre-approval inspection readiness. He has authored or co-authored more than forty peer-reviewed technical articles on industrial peptide chemistry and serves as a contributing reviewer to industry technical conferences.
Procurement & Supplier Evaluation
Alongside the manufacturing profiles, Peptide Forge publishes the Supply Chain Transparency Index — an editorial, procurement-grade due-diligence framework evaluating peptide vendors across six documentation criteria adapted from ICH Q7 and ISO 9001:2015 clause 8.4. The index is intended for procurement officers, quality leads, and process-development teams who need a documentation-first screen for vendor qualification. It is non-commercial; Peptide Forge does not sell peptides, does not accept paid supplier placement, and does not maintain a financial relationship with any vendor evaluated in the index.
Contact
For documentation requests, technical clarifications, or specification questions, see the contact page.